These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Corfas G; Roy K; Buxbaum JD Nat Neurosci; 2004 Jun; 7(6):575-80. PubMed ID: 15162166 [TBL] [Abstract][Full Text] [Related]
29. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway. Deng C; Pan B; Engel M; Huang XF Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757 [TBL] [Abstract][Full Text] [Related]
30. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Georgieva L; Moskvina V; Peirce T; Norton N; Bray NJ; Jones L; Holmans P; Macgregor S; Zammit S; Wilkinson J; Williams H; Nikolov I; Williams N; Ivanov D; Davis KL; Haroutunian V; Buxbaum JD; Craddock N; Kirov G; Owen MJ; O'Donovan MC Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12469-74. PubMed ID: 16891421 [TBL] [Abstract][Full Text] [Related]
31. Increased l1 retrotransposition in the neuronal genome in schizophrenia. Bundo M; Toyoshima M; Okada Y; Akamatsu W; Ueda J; Nemoto-Miyauchi T; Sunaga F; Toritsuka M; Ikawa D; Kakita A; Kato M; Kasai K; Kishimoto T; Nawa H; Okano H; Yoshikawa T; Kato T; Iwamoto K Neuron; 2014 Jan; 81(2):306-13. PubMed ID: 24389010 [TBL] [Abstract][Full Text] [Related]
34. Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1. O'Tuathaigh CM; Fumagalli F; Desbonnet L; Perez-Branguli F; Moloney G; Loftus S; O'Leary C; Petit E; Cox R; Tighe O; Clarke G; Lai D; Harvey RP; Cryan JF; Mitchell KJ; Dinan TG; Riva MA; Waddington JL Schizophr Bull; 2017 Jan; 43(1):214-225. PubMed ID: 27613806 [TBL] [Abstract][Full Text] [Related]
35. Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons. Longart M; Chatani-Hinze M; Gonzalez CM; Vullhorst D; Buonanno A Brain Res Bull; 2007 Jul; 73(4-6):210-9. PubMed ID: 17562386 [TBL] [Abstract][Full Text] [Related]
36. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Brennand K; Savas JN; Kim Y; Tran N; Simone A; Hashimoto-Torii K; Beaumont KG; Kim HJ; Topol A; Ladran I; Abdelrahim M; Matikainen-Ankney B; Chao SH; Mrksich M; Rakic P; Fang G; Zhang B; Yates JR; Gage FH Mol Psychiatry; 2015 Mar; 20(3):361-8. PubMed ID: 24686136 [TBL] [Abstract][Full Text] [Related]
37. Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. Schmitt A; Parlapani E; Gruber O; Wobrock T; Falkai P Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():35-9. PubMed ID: 18985292 [TBL] [Abstract][Full Text] [Related]
38. Copy number variations (CNVs) in human pluripotent cell-derived neuroprogenitors. Corrales NL; Mrasek K; Voigt M; Liehr T; Kosyakova N Gene; 2012 Sep; 506(2):377-9. PubMed ID: 22820389 [TBL] [Abstract][Full Text] [Related]
39. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909 [TBL] [Abstract][Full Text] [Related]
40. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Fazzari P; Paternain AV; Valiente M; Pla R; Luján R; Lloyd K; Lerma J; Marín O; Rico B Nature; 2010 Apr; 464(7293):1376-80. PubMed ID: 20393464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]